Research / UI / Fundamental state Inspectable configuration
State dimensions Filing 0001511737-26-000056 General Corporate
Capex intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.60% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.36% · OPTIONAL · VALID
Revenue growth 65th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
27.22% · CORE · VALID
Inventory pressure 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
23.84% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
46.16% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
36.21% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.24% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.23% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 60 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 0.71%
Current 0.60%
Delta -0.10% Cash Generation Increased
Previous 21.29%
Current 28.36%
Delta 7.08% Growth Increased
Previous 18.67%
Current 27.22%
Delta 8.55% Inventory Pressure Decreased
Previous 82.97%
Current 23.84%
Delta -59.14% Margin Decreased
Previous 47.03%
Current 46.16%
Delta -0.87% Profitability Decreased
Previous 36.90%
Current 36.21%
Delta -0.69% R And D Intensity Decreased
Previous 6.57%
Current 6.24%
Delta -0.34% Sbc Intensity Increased
Previous 0.20%
Current 0.23%
Delta 0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2021
Similarity 82%
Compared 8 dimensions
Coverage 100% Growth 30.0 · Margin 5.0 · Profitability 0.0 · Sbc Intensity 25.0 · Capex Intensity 30.0 · Cash Generation 15.0 · R And D Intensity 5.0 · Inventory Pressure 0.0 Dec 31, 2025
Similarity 78%
Compared 8 dimensions
Coverage 100% Growth 20.0 · Margin 10.0 · Profitability 5.0 · Sbc Intensity 5.0 · Capex Intensity 20.0 · Cash Generation 15.0 · R And D Intensity 5.0 · Inventory Pressure 50.0 Jun 30, 2025
Similarity 78%
Compared 8 dimensions
Coverage 100% Growth 15.0 · Margin 25.0 · Profitability 25.0 · Sbc Intensity 35.0 · Capex Intensity 10.0 · Cash Generation 20.0 · R And D Intensity 20.0 · Inventory Pressure 10.0 Dec 31, 2020
Similarity 75%
Compared 6 dimensions
Coverage 75% Growth 35.0 · Margin 10.0 · Profitability 5.0 · Sbc Intensity 30.0 · R And D Intensity 0.0 · Inventory Pressure 40.0 Jun 30, 2019
Similarity 74%
Compared 8 dimensions
Coverage 100% Growth 25.0 · Margin 30.0 · Profitability 35.0 · Sbc Intensity 35.0 · Capex Intensity 0.0 · Cash Generation 30.0 · R And D Intensity 15.0 · Inventory Pressure 20.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.